血小板基因数据库HLA相容性配合效率的分析

陈江天 ,  许先国 ,  洪小珍 ,  马开荣 ,  郭峻峰 ,  章伟 ,  朱发明

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1105 -1109.

PDF (1219KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1105 -1109. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.08.016
论著

血小板基因数据库HLA相容性配合效率的分析

作者信息 +

Analysis of the efficiency of HLA-compatible platelet matching using a platelet genotype database

Author information +
文章历史 +
PDF (1247K)

摘要

目的 评估单个血小板基因数据库在 HLA 基因配合搜寻和应用的运行效率,比较不同配型策略、医院以及初次与再次申请模式间的效率。方法 收集本中心 2025 年 12 月 1 日-2026 年 5 月 31 日的血小板基因配型申请数据。 根据流程定义 4 个时间段,从临床医院申请到血站接收确认所需时间(Δt1)、血站确认申请信息到完成血小板基因数据库搜寻所需时间(Δt2)、血站完成搜寻到能提供配合血小板实物所需时间(Δt3)、从临床医院申请到血站能提供配合血小板实物所需时间(Δt4)。 按申请历史分为初次申请与再次申请,按配型策略分为速度优先配型策略与经典配型策略,并比较各组的效率差异。结果 共纳入 1 051 次有效配型申请,Δt1、Δt2、Δt3、Δt4 中位数分别为 6. 2 h、0. 1 h、0. 2 h、11. 5 h,55. 9%的基因配型可在申请当天匹配到血小板实物。 速度优先配型策略 Δt4 中位数明显短于经典配型策略(5. 2 h vs 39. 6 h,P<0. 001)。 不同医院的 Δt4 中位时间有差异(P<0. 001),时间最短为 4. 4 h。 再次申请的 Δt4 中位时间为 6. 9 h,显著短于初次申请的 27. 7 h(P<0. 001)。结论 血小板基因数据库在 HLA 基因配合搜寻和应用的效率上可以满足临床需求,优化不同配型策略和医院申请流程可缩短获得配合血小板的时间。

Abstract

Objective To evaluate the operational efficiency of a single-center platelet genotype database in HLA geno-type-matched platelet search and applcation, and to compare the efficiency among different matching strategies, hospitals, and between first-time versus repeat application modes. Methods Data on platelet genotype-based matching applications from December 1, 2025, to May 31, 2026, at our center were collected. Four time intervals were defined according to the workflow:the time from clinical hospital application to blood center receipt confirmation (Δt1); the time from blood center confirmation to completion of platelet gene database search (Δt2);the time from completion of database searching to availa-bility of compatible platelet products (Δt3); and the time from clinical hospital application to availability of compatible platelet products (Δt4). Applications were classified as first-time or repeat based on application history, and as speed-prior-ity matching strategy or classical matching strategy based on matching approach, with efficiency differences compared across the groups. Results A total of 1 051 valid matching applications were included. The median values of Δt1, Δt2, Δt3, and Δt4 were 6. 2 h, 0. 1 h, 0. 2 h, and 11. 5 h, respectively. Overall, 55. 9% of genotype-based matches resulted in compati-ble platelets being available on the same day. The median Δt4 of the speed-priority strategy was significantly shorter than that of the classical strategy (5. 2 h vs 39. 6 h, P<0. 001). Median Δt4 differed significantly among hospitals (P<0. 001), with the shortest being 4. 4 h. The median Δt4 for repeat applications was 6. 9 h, significantly shorter than that for first-time ap-plications (27. 7 h, P<0. 001). Conclusion The platelet gene database demonstrates sufficient efficiency in HLA geno-type-matched platelet searching and application to meet clinical demands. Optimizing matching strategies and hospital appli-cation workflows may shorten the time for obtaining compatible platelets.

关键词

血小板基因配型 / 运行效率 / 配型策略 / 血小板基因数据库

Key words

platelet genotype matching / operational efficiency / matching strategy / platelet gene database

引用本文

引用格式 ▾
陈江天,许先国,洪小珍,马开荣,郭峻峰,章伟,朱发明. 血小板基因数据库HLA相容性配合效率的分析[J]. 中国输血杂志, 2026, 39(8): 1105-1109 DOI:10.13303/j.cjbt.issn.1004-549x.2026.08.016

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

PRODGER C F, RAMPOTAS A, ESTCOURT L J, et al. Platelet transfusion:alloimmunization and refractori-ness[J].Semin Hematol,2020,57(2):92-99.

[2]

YOUK H J, HWANG S H, OH H B, et al. Evaluation and management of platelet transfusion refractoriness[J].Blood Res,2022,57(S1):6-10.

[3]

SCHMIDT A E, REFAAI M A, COPPAGE M. HLA-mediated platelet refractoriness[J].Am J Clin Pathol, 2019,151(4):353-363.

[4]

梁雅珺,王华,赵沛喆,等. 不同血小板配型方案在血小板输注无效患者中的输注效果分析[J].中华医学杂志,2024,104(11):865-869.

[5]

LIANG Y J, WANG H, ZHAO P Z, et al. Analysis of transfusion effect of different platelet matching schemes in patients with platelet transfusion refractoriness[J].Natl Med J China,2024,104(11):865-869.

[6]

夏文霞,杨帆,车华涛,等. 深圳地区 HPA 抗原抗体多样性及其在血小板输注中的应用[J].中国实验血液学杂志,2026,34(2):426-431.

[7]

XIA W J, YANG F, CHE H T, et al. Diversity of HPA antigen-antibody and its application in platelet transfu-sion in Shenzhen area[J].J Exp Hematol, 2026, 34 (2):426-431.

[8]

倪修文,陈涛,罗振,等. 嘉兴地区血小板献血者 HLA/ HPA 基因分型数据库的建立及血小板基因配型精准输血后的临床疗效研究[J].全科医学临床与教育, 2025,23(10):933-935.

[9]

NI X W, CHEN T, LUO Z, et al. Establishment of an HLA/ HPA genotyped platelet donor database in Jiaxing region and clinical efficacy study of precise platelet trans-fusion after genotype-matched platelet transfusion[J].Clin Educ Gen Pract,2025,23(10):933-935.

[10]

刘铮,孙亚敏,彭鑫,等. 从供者流失对血小板库建库策略进行分析评估[J].中国输血杂志,2025,38(2): 238-243.

[11]

LIU Z, SUN Y M, PENG X, et al. Analysis and evalua-tion of platelet bank establishment strategy from the per-spective of donor loss[J].Chin J Blood Transfusion, 2025,38(2):238-243.

[12]

张丽,刘铮,张伯伟,等. 郑州地区固定单采血小板捐献人群血小板供者库建立分析[J].实验与检验医学, 2022,40(3):374-378.

[13]

ZHANG L, LIU Z, ZHANG B W. Analysis of the estab-lishment of a platelet donor bank among regular apheresis platelet donors in Zhengzhou region[J].Exp Lab Med, 2022,40(3):374-378.

[14]

朱发明,毛伟,张志欣. 血小板捐献者血型资料数据库的建设与应用展望[J].中国输血杂志,2019,32(5): 413-416.

[15]

ZHU F M, MAO W, ZHANG Z X. Establishment of the genotype database for apheresisplatelet donors and their application prospect[J]. Chin J Blood Transfusion, 2019,32(5):413-416.

[16]

许先国,刘瑛,陈舒,等. 血小板数字化配型信息体系构建及其应用[J].中国输血杂志, 2022, 35(10): 1081-1084.

[17]

XU X G, LIU Y, CHEN S, et al. Construction and ap-plication of platelet virtual matching information system[J].Chin J Blood Transfusion, 2022, 35(10):1081-1084.

[18]

何吉. 血小板配型及相容性输注的专家共识[J].浙江医学, 2021,43(13):1367-1371.

[19]

HE J. Expert consensus on platelet matching and com-patible transfusion[J].Zhejiang Med J, 2021,43(13): 1367-1371.

[20]

MARSH J C, STANWORTH S J, PANKHURST L A, et al. An epitope-based approach of HLA-matched platelets for transfusion:a noninferiority crossover randomized trial[J].Blood,2021,137(3):310-322.

[21]

EL-AWAR N. HLA epitopes-empirically defined as con-formational amino acids sequences of the HLA antigen and are likely to be part of the binding sites of anti-HLA antibodies[J].Hum Immunol,2022,83(3):204-218.

基金资助

中国输血协会威高科研基金重点项目(CSBT-MWG-2023-01)

浙江省卫生健康行业科技计划项目(2025HY0302)

AI Summary AI Mindmap
PDF (1219KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉